INSIGHTS ON LIQUID DOSE MANUFACTURING

LIQUID DOSE MANUFACTURING SOLUTIONS

  • Process stability, high efficiency and customizable features are crucial issues related to glass packaging manufacturing. Our ampoule forming line perfectly matches these needs, guaranteeing the highest performance thanks to cutting-edge capabilities, such as its automatic inspection system and electric rotational oven, which provides higher product handling stability.

  • Designed to be used in research and small scale manufacturing settings, this technology is ideally sized to be used in existing isolators, RABS and bio-safety cabinets, providing 100% fill weight verification - Up to 360 containers/hour.

  • The aseptic/sterile Fill-Finish equipment solutions need to be cGMP compliant, dependable and accurately designed to comply with the most recent revisions of the “Annex 1 Manufacture of Sterile Medicinal Products guidelines”. Newly designed equipment needs to accommodate for small batches, various speeds and containers, including RTU / RTF (Ready To Use or Ready To Fill) bottles, vials, cartridges, syringes and pre-sterile nested trays. Moreover, the filling equipment solution should also improve the ergonomic use for operators and maximize cleanroom efficiency.

  • When you need to provide a clean, contained environment for the safe handling of powders in dispensing, weighing, sampling, or subdivision operations, our PharmAir booths are a highly effective option. Complete containment solutions based around an innovative range of Downflow Containment Booths that bring different features and benefits to your application. But all have one thing in common: they give a Guaranteed Working Environment.

  • Cell and gene therapies have increased in popularity in recent years, and thanks to their ability to provide one-time treatments these therapies will play a significant role in treating some of the world's most challenging diseases. These drug products treat patients afflicted with genetic disorders and cancers by targeting the source of disease and altering its genetic makeup to eliminate its cause or symptoms. These therapies are expensive and complex and have been proven effective in numerous cases, but they present a challenge in producing them at scale and at a reasonable cost.